by InfluencER | Jan 20, 2022 | Pharma
News Royal Emerald Pharmaceuticals (REP) Receives Federal Licenses For Cannabis Research By The company received 4 licenses to grow, research, develop, and manufacture Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses...
by InfluencER | Jan 18, 2022 | Pharma
Creso Pharma has an eye on North America with a new crop of cannabis-credentialed executives Creso Pharma Ltd has launched the next stage of its growth strategy, appointing executives with strong backgrounds in the lucrative cannabis market. In a push to strengthen...
by InfluencER | Jan 6, 2022 | Pharma
Pfizer wants in on the cannabis game. Will you be buying Pharma Weed? Most consumers say absolutely not. You may not have heard the wonderful news. Our great overlords and global saviors at Pfizer announced their intentions to get into the medical cannabis market via...
by InfluencER | Dec 28, 2021 | Pharma
Although there is still no single recognized and approved cure for cancer, there are many treatments that help people fight it off. This depends, of course, on the type, stage it’s been discovered, overall patient health, and many other factors, some of which are...
by InfluencER | Dec 27, 2021 | Pharma
Cannbit-Tikun Olam will produce various medical cannabis products for Teva Israel, a marketing arm of Teva Pharmaceuticals (NYSE: TEVA). What Happened The Tel Aviv, Israel-based cannabis company confirmed Monday it has signed a collaboration agreement with Teva, under...
by InfluencER | Dec 22, 2021 | Pharma
republican lawmakers in the House and Senate have introduced new legislation that would make it easier for scientists to research Schedule I drugs like marijuana and psilocybin. Companion bills filed by Sen. Bill Cassidy (R-LA) and Rep. Morgan Griffith (R-VA) largely...
